Information Library
Results for: Business transformation - Flexible outsourcing - Consulting
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Quintiles Backs Change to Marketing Mix as NHS Reforms Take Hold
Press Release — READING, UK – 30 May, 2012 – Quintiles has released the first in a series of briefing papers looking at how market access strategies can
-
UK Market Access Insight Brief
Podcast — May 30, 2012
Insight Briefing series on Market Access in key European countries -
Quintiles Infosario Clinical Trial Management System Fact Sheet
Brochure — January 17, 2012
A fully hosted, global Clinical Trial Management System(CTMS) that provides scalable functionality across multiple business processes. A key component of our Systems as a Service offering, the Quintiles Infosario CTMS provides a centralized location for capturing, viewing, and sharing clinical trial data—from site identification to study closeout. -
Challenging Traditional Outsourcing Models Using Core And Non-Core Assessment
Presentation — June 30, 2010
-
Outsourcing as strategic alternative to your own headcount
Presentation — May 25, 2010
Approach of Roche Italy in outsourcing their primary care sales force to Quintiles -
Commercial – Identify, Promote and Prove Treatment Value
Brochure — April 1, 2010
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. -
QUINTILES AND MOVETIS ANNOUNCE STRATEGIC ALLIANCE
Press Release — January 28, 2010 - Quintiles announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.
-
Poised for success
Presentation — June 16, 2009
Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility -
Rebalancing Risk to Transform R&D
White Paper — June 3, 2009
A strategic approach to re-balancing the main components of biopharma company risk: portfolio, operational and resource. -
Adrian McKemey, Ph.D.
Hear from the Experts — March 25, 2009
Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting.
